Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Squamous Cell Carcinoma of the Head and Neck, Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL), Locally Advanced or Metastatic ER+ HER2- Breast Cancer.
Sponsors: Pfizer, Takeda.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has 3 clinical trials on record, with 2 currently active. Their work covers Squamous Cell Carcinoma of the Head and Neck, Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL), Locally Advanced or Metastatic ER+ HER2- Breast Cancer.
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.